Wall Street sent mixed signals on Saturday, with upgrades and target cuts spread across consumer, tech, and healthcare names.
Take-Two Interactive drew the most bullish attention. Analysts lifted the consensus target to $279.45, up from $279.11. The gaming firm carries a $44B market cap. Almost all 30 covering analysts rate it a Buy — a near-unanimous view that's rare outside mega-cap tech.
Eli Lilly also got a boost. The consensus price target rose to $1,218, from $1,216. The pharma giant now sits at a $980B market cap. Analysts remain firmly in the bull camp, with 22 Buy ratings against just one Sell.
Bears moved against Accenture. The consensus target dropped to $197.65 from $208.16 — a $10 cut. That's a meaningful reduction for a $78B company. The split between 13 Holds and 15 Sells signals real caution on IT services demand.
Lululemon also faced target trims. The consensus fell to $132.16 from $133.74. Short interest sits at 7.5% of free float. Two analysts hold Sell ratings, unusual for a brand that was a market darling just two years ago.
Datadog received a new initiation with a $241 target. Analysts overwhelmingly back the cloud monitoring firm, with 43 Buy ratings.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
